证券代码：603829 证券简称：洛凯股份 公告编号：2026-008 江苏洛凯机电股份有限公司关于 增加部分募投项目实施地点并延期的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 江苏洛凯机电股份有限公司（以下简称"洛凯股份"或"公司"）于2026年2月27日召开了第四届董事会第 八次会议，审议通过了《关于增加部分募投项目实施地点并延期的议案》，同意募集资金投资项目"新 能源及智能配网用新型电力装备制造项目"（以下简称"募投项目"）新增实施地点"常州经济开发区潞城 街道五一路257号"并将募投项目达到预定可使用状态延期至2026年12月。 本次增加部分募投项目实施地点并延期事项未改变募集资金投资用途、投资总额和实施主体，不会对募 投项目的实施造成实质性不利影响。中泰证券股份有限公司（以下简称"保荐人"）对该事项出具了明确 的核查意见，该事项无需提交公司股东会审议。现将具体情况公告如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意江苏洛凯机电股份有限公司向不特定对象发行可转换公司债券 注册的批复》（ ...

南财智讯1月27日电，京泉华公告，公司于2026年1月27日召开第五届董事会第五次会议，审议通过《关 于部分募投项目结项并将节余募集资金永久补充流动资金及部分募投项目延期的议案》，同意将募投项 目"河源新能源磁集成器件智能制造项目"结项；该项目已达到预定可使用状态。截至2025年12月31日， 该项目节余募集资金1638.36万元（包含现金管理收益及利息，具体金额以资金转出当日募集资金专户 实际余额为准），除预留约1507.48万元用于支付已签订合同但尚未支付的合同款外，拟将上述节余募 集资金1638.36万元永久补充流动资金，用于公司日常生产经营。募投项目资金全部使用完毕后，公司 将注销相应募集资金专户。 ...

Core Viewpoint - Chengdu Kanghua Biological Products Co., Ltd. has announced a prudent adjustment to the implementation schedule of its fundraising project "Vaccine Production Expansion Project," moving the expected completion date from December 31, 2025, to June 30, 2026 [1][2] Group 1: Project Adjustment Details - The adjustment only involves the project timeline and does not change the implementation entity, location, or the use of raised funds [1] - The project has completed workshop construction, equipment debugging, trial production, drug registration site inspection, GMP compliance checks, and is currently in the supplementary application review stage [1] Group 2: Regulatory and Management Insights - The adjustment is not due to project obstacles but is a necessary coordination with regulatory processes [2] - The company aims to ensure that the project operates in a fully compliant and stable manner by dynamically optimizing expectations based on actual approval rhythms [2] Group 3: Strategic Importance - The expansion project is a strategic move for Kanghua Biological to solidify core production capacity and align with future market demands [2] - Despite the short-term schedule adjustment, the completion of the main engineering and the most challenging review stages has not affected the long-term strategic value and potential contribution to performance [2]

Core Viewpoint - The company has completed the "TianNeng Heavy Industry WuChuan 150MW Wind Power Project" and the "Jiangsu TianNeng Offshore Wind Power Equipment Manufacturing Base Technical Renovation and Phase II Expansion Project," achieving the predetermined usable status [1] Financial Summary - As of December 10, 2025, the total funds raised for the two projects and supplementary working capital projects amount to 1.356 billion yuan, with a surplus of 155 million yuan [1] - The company plans to permanently supplement the surplus funds into working capital, and the related special accounts will be canceled [1] Approval Process - The matter has been approved by the company's Board of Directors and the Audit Committee, pending review by the shareholders' meeting [1] - The sponsor institution, Zhongtai Securities, has no objections to this decision [1]

Core Viewpoint - The company has completed the investment project "Intelligent Manufacturing Overall Solution R&D and Industrialization Project" funded by the issuance of convertible bonds in 2021, and will conclude this project [1] Group 1: Project Completion and Fund Allocation - The remaining raised funds amounting to 283.4181 million yuan will be allocated to new investment projects and to permanently supplement the working capital of its wholly-owned subsidiary, Dongguan Tuosida Technology Co., Ltd [1] - The new investment project, "CNC Machine Tool R&D and Industrialization Project," has a total investment of 261.5568 million yuan, with 234 million yuan sourced from the raised funds [1] - A small portion of the remaining funds, 49.4181 million yuan (including interest income), will be used to permanently supplement the working capital of Tuosida Technology to meet its daily operational needs [1]

Core Viewpoint - Wanfu Biology has decided to suspend the implementation of certain fundraising projects due to significant changes in the internal and external operating environment, aiming to avoid resource waste and reduce operational costs while maintaining long-term interests for the company and its shareholders [1][3]. Group 1 - The company held its 17th meeting of the 5th Board of Directors on November 14, where it approved the proposal to re-evaluate and suspend the implementation of certain fundraising projects [3]. - The decision to suspend the "Knowledge City Production Base Construction Project" will not change the project’s implementation subject, method, use of raised funds, or investment scale [3].

Core Viewpoint - Beijing Wajinke Information Technology Co., Ltd. has approved the adjustment of surplus fundraising for the "Research and Operation Base Construction Project" to be used for the "Mobile Marketing Service Business Upgrade Project" to enhance fundraising efficiency [1][2] Fundraising Overview - The total amount of funds raised by the company in 2022 was RMB 591.26 million, with actual funds received after deducting issuance costs amounting to RMB 517.08 million [1] - The funds were verified by Rongcheng Accounting Firm and were stored in a dedicated account with a tripartite supervision agreement signed with the supervising bank and sponsor [1] Fundraising Account Cancellation - The fundraising project "Research and Operation Base Construction Project" has been completed, and the company has canceled the corresponding special fundraising account, including interest and investment income [2] - The cancellation procedures for the special fundraising account have been completed, and the relevant supervision agreement has been terminated [2]

Core Viewpoint - The company has decided to re-evaluate and temporarily suspend certain fundraising investment projects due to changes in market conditions and technological advancements in the industry [3][4]. Fundraising Overview - The company raised a total of RMB 815,978,425.74 by issuing 240,134,144 shares at a price of RMB 3.45 per share [1]. - All raised funds have been deposited into a special account approved by the board of directors, with a tripartite supervision agreement signed among the company, the sponsor, and the commercial bank [2]. Investment Project Adjustments - The adjusted investment projects include the key equipment production line for panel boxes and the intelligent transformation project for high-end wear-resistant parts [2]. - The total investment amount for the projects was adjusted from RMB 82,846.28 million to RMB 81,597.84 million, with a total investment of RMB 108,801.61 million [2]. Project Re-evaluation and Suspension - The high-end wear-resistant parts manufacturing line project has been delayed compared to the original plan, requiring a re-evaluation based on the latest industry technologies and market demands [3]. - The decision to suspend the project is based on the evolving industry requirements for materials and processes, which have introduced new materials that differ from the original plan to produce metal liners [3][4]. Impact of Project Suspension - The re-evaluation and suspension of the investment projects are seen as prudent decisions that do not harm shareholder interests and comply with relevant regulations [4][5]. - The company believes that this decision will optimize resource allocation, reduce investment risks, and lay a foundation for future market opportunities [4]. Approval Procedures - The board of directors and the supervisory board have approved the re-evaluation and suspension of the high-end wear-resistant project [5]. - The sponsor has confirmed that the approval procedures comply with the relevant regulations and that the decision does not harm shareholder interests [5][6].

Core Viewpoint - The company has approved its 2025 semi-annual report and related proposals during the board meetings, including a share buyback plan and governance structure revisions [3][9][19]. Group 1: Company Overview - The company is Guangdong DeGuan Film New Materials Co., Ltd., with the stock code 001378 [7]. - The board of directors and the supervisory board have both confirmed the accuracy and completeness of the information disclosed [7][29]. Group 2: Financial and Operational Highlights - The company plans to repurchase shares using its own funds and a special loan for stock repurchase, with a total amount between RMB 20 million and RMB 40 million, and a maximum price of RMB 32.44 per share [5][19]. - As of June 30, 2025, the company has not yet implemented the share buyback [6]. Group 3: Board Meeting Resolutions - The board approved the 2025 semi-annual report and its summary, as well as a special report on the use of raised funds [9][12]. - The board has decided to revise the company's articles of association, eliminating the supervisory board and transferring its powers to the audit committee [14][17]. - The board approved the extension of certain fundraising project deadlines, specifically for the "Functional Film and Functional Masterbatch Expansion and Technical Transformation Project" and the "Laboratory and Testing Upgrade Technical Transformation Project" [19][32]. Group 4: Profit Distribution - The wholly-owned subsidiary, Guangdong DeGuan Packaging Materials Co., Ltd., plans to distribute RMB 100 million in profits to the company, which represents 17.52% of its distributable profits as of June 30, 2025 [22]. Group 5: Upcoming Events - The company will hold its second extraordinary general meeting of 2025 on September 1, 2025 [25].

Core Viewpoint - Aiwai Electronics announced the completion of several fundraising projects and the reallocation of surplus funds to other projects, indicating a strategic shift in investment focus [2] Summary by Relevant Sections - **Completion of Fundraising Projects** - The company has completed and achieved the intended usable status for the projects: "Intelligent Audio Chip R&D and Industrialization," "5G RF Device R&D and Industrialization," and "Motor Driver Chip R&D and Industrialization" [2] - **Reallocation of Surplus Funds** - Surplus funds from the completed projects will be redirected to the "High-Performance Analog Chip R&D and Industrialization Project" [2] - **Project Extension** - The "High-Performance Analog Chip R&D and Industrialization Project" has been approved for an extension [2] - **No Shareholder Meeting Required** - The decisions made regarding the projects do not require submission for shareholder meeting approval [2]